MAP9/ERCC3 signaling cascade: A new insight on understanding the chromosomal instability in hepatocellular carcinoma
暂无分享,去创建一个
[1] Jun Yu,et al. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3 , 2020, EBioMedicine.
[2] Jun Yu,et al. MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer , 2019, Clinical Cancer Research.
[3] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[4] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[5] J. Brondello,et al. Induction of ASAP (MAP9) contributes to p53 stabilization in response to DNA damage , 2012, Cell cycle.
[6] Ronald A. DePinho,et al. Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.
[7] C. Prigent,et al. ASAP, a human microtubule-associated protein required for bipolar spindle assembly and cytokinesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] Rui Li,et al. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma , 2005, Oncogene.
[9] Francis Simon,et al. Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. , 2002, Biochimica et biophysica acta.
[10] C. Rao,et al. Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. , 2017, Carcinogenesis.